Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-06-000622
Filing Date
2006-02-13
Accepted
2006-02-13 14:39:49
Documents
1
Group Members
BIOTECH INVEST N V

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A w17505dsc13gza.htm SC 13G/A 75143
  Complete submission text file 0000950133-06-000622.txt   77249
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 06602771
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000